CD8+ T cells, as central effectors of cellular immunity, mediate tumor cell lysis via MHC-I-restricted antigen recognition, migrating along chemokine gradients to infiltrate tumor parenchyma and executing cytotoxicity through granzyme-perforin-mediated exocytosis and Fas/FasL death receptor signaling (81). The gene discussed is PRF1; the disease is neoplasm.